Targeting the EGFR-family for Therapy: Biological Challenges and Clinical Perspective

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|19|2672-2679

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.19, 2012-06, pp. : 2672-2679

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Bcl-2 family for cancer therapy

By Thomas Shibu   Quinn Bridget A   Das Swadesh K   Dash Rupesh   Emdad Luni   Dasgupta Santanu   Wang Xiang-Yang   Dent Paul   Reed John C   Pellecchia Maurizio   Sarkar Devanand   Fisher Paul B  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 61-75

Informa Healthcare

Access to resources Recommend Favorite

EGFR-targeting agents in oncology

By Garofalo Sonia   Rosa Roberta   Bianco Roberto   Tortora Giampaolo  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 8, 2008-08 ,pp. : 889-901

Informa Healthcare

Access to resources Recommend Favorite

Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers

By Desai Monica Dandona   Saroya Bikramajit Singh   Lockhart Albert Craig  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 341-356

Informa Healthcare

Access to resources Recommend Favorite

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite

Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy

By  

Current Pharmaceutical Design, Vol. 22, Iss. 16, 2016-05 ,pp. : 2358-2388

Bentham Science Publishers

Access to resources Recommend Favorite